Testing effectiveness (Phase 2)Ended earlyNCT02228785
What this trial is testing
The Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer
Who this might be right for
Colorectal Cancer
Cancer Advances Inc. 5
Showing 20 of 0 results